Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02977494
Brief Title: Daratumumab in Combination With Bortezomib and Dexamethasone in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma and Severe Renal Impairment (GMMG-DANTE)

First Submitted : November 17, 2016
First Submitted that Met QC Criteria : November 25, 2016
First Posted : November 30, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : March 24, 2017
Last Update Posted : March 27, 2017